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ABSTRACT To evaluate the effects of chronic lead exposure on the nervous system in adults, a set
of neurobehavioural and electrophysiological tests was administered to 99 lead exposed foundry
employees and 61 unexposed workers. Current and past blood lead concentrations were used to
estimate the degree of lead absorption; all previous blood lead concentrations had been less than
or equal to 90 /ig/100 ml. Characteristic signs (such as wrist extensor weakness) or symptoms
(such as colic) of lead poisoning were not seen. Sensory conduction in the sural nerve was
modestly slowed by lead exposure but conduction in the ulnar and peroneal nerves was not
affected. By contrast, various neurobehavioural functions deteriorated with increasing lead bur-
den. Workers with blood lead concentrations between 40 and 60 ,ug/100 ml showed impaired
performance on tests of verbal concept formation, visual/motor performance, memory, and
mood. Thus impairment in central nervous system function in lead exposed adults occurred in the
absence of peripheral nervous system derangement and increased in severity with increasing lead
dose.
Although the earliest effect of systemic lead absorp-
tion is the inhibition of various enzyme systems, par-
ticularly those regulating haem synthesis' and
mitochondrial respiration,2 organ dysfunction,
sufficient to cause symptoms, usually first occurs in
the nervous system. In the past3 lead poisoning was
often associated with signs of toxic encephalopathy
and overt peripheral neuropathy. As levels of
exposure have fallen, lead neurotoxicity has been
manifested by more subtle disturbances of affect,
psychomotor function, and nerve conduction.4
Epidemiological investigations have not consis-
tently characterised these disorders, some have
shown slowing of motor nerve conduction,5-8 others
have not.9 0 Impaired psychomotor function has
been reported by most groups'I'' but the degree of
impairment found has varied. These inconsistencies
may be attributed, in part, to limitations in study
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design and inadequate standardisation of techni-
ques. All previous studies, except that of Spivey and
colleagues,9 10 have been cross sectional investiga-
tions comparing a group of lead exposed workers
with an unexposed referent population. In such
studies the course of exposure related disorders is
not directly evaluated.'5 Despite statements in most
papers that "standard techniques were used," the
degree to which technical factors (stimulus intensity
and limb temperature in nerve conduction testing,
for example) were controlled is unclear. More
importantly, many fail adequately to control for
potential confounding factors such as age and educa-
tion level in neurobehavioural measures.
Currently, nerve conduction velocity measure-
ment is viewed as an early indicator of lead induced
nervous system damage5 and, as such, is used widely
in the clinical assessment of lead exposed workers.
Despite the demonstration of adverse effects on
behavioural function in lead workers with modest
levels of absorption (blood lead concentrations be-
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tween 40 and 60 ,ug/dl)'4 neurobehavioural testing is
not used as frequently in the evaluation of patients.
In the report of Repko et al both neurobehavioural
and neurophysiological techniques were used, but
the relative value of these tests in the early detection
of lead toxicity was not directly evaluated."
In the present report we describe an investigation
of lead exposed workers designed to evaluate the
effects of chronic low level lead exposure on the
nervous system. By applying a comprehensive set of
neurobehavioural and neurophysiological tests to
groups with varying degrees of lead absorption, we
are able to explore dose response relationships in
workers with chronic exposure to lead. By using
both types of testing in the study, we are also able to
identify the techniques most sensitive to the mani-
festations of subclinical lead neurotoxicity. The pre-
sent paper describes the first year of a three year
project.
Methods
SUBJECTS
Between May 1980 and June 1981, 106 lead
exposed foundry workers were tested. They consti-
tuted 91% of the current lead exposed production
workers at the foundry: the remaining 9% either
refused to participate in our study or were absent
from work during the period of testing. Workers
already employed in May 1980 were tested then,
those hired during the following 13 months were
tested soon after beginning work.
Sixty five workers in an assembly plant located
adjacent to the foundry were also tested. Detailed
job histories were obtained and a walk through plant
survey was performed to ensure that the assembly
workers were not exposed to lead or other neurotox-
ins. They were recruited from four work areas, em-
ploying 110 individuals, whose job duties and pay
rates closely resembled those of the lead exposed
workers. The unexposed workers resided in the
same area as the exposed workers and most had
attended the same schools. All tested workers were
white. and spoke English as their first language.
None had blood lead concentrations over 90 ,tg/dl
since beginning work at the plant, and none had
been diagnosed as having lead poisoning.
Workers who drank heavily or had a history of
severe head injury were not tested. Eleven individu-
als (seven exposed and four referents) were tested
but were subsequently excluded from the data
analysis because of insufficient data or because they
had histories of acute alcohol use, previous alcohol-
ism, psychoactive drug use, prior lead or solvent
exposure, diabetes, or meningitis. Subsequent analy-
ses therefore, relate to the residual 99 exposed and
61 referent workers studied. We also deleted data
on certain tests from an individuarls file if we
thought that a confounding factor would affect per-
formance on those tests but not on others using
exclusion criteria which were developed a priori.
Individuals were evaluated for exclusion without
knowledge of test outcome or exposure. Individual
results for the 14 with right arm or hand injury were
deleted from analyses of tests of ulnar nerve conduc-
tion and the Santa Ana test using the right hand.
The 13 with left arm or hand injury were removed
from analyses of data on the Santa Ana test (left
hand). We removed data on two individuals with
foot or leg injuries from sural and peroneal nerve
conduction analyses, two with epilepsy from all
neurobehavioural tests, and one with frostbite and
one with knee surgery from sural and peroneal
nerve conduction analyses. Separate analyses
showed that the test scores of these excluded indi-
viduals differed little from those not excluded.
Nevertheless, in view of the prospective nature of
this study, we thought it advisable to remove them
from these and subsequent analyses to reduce
potential confounding effects. All participants were
informed of the risks and benefits of participation in
the study and all medical data were treated
confidentially. The employer had access only to data
required by law under existing standards of the
Occupational Safety and Health Administration.
EVALUATIVE PROCEDURES
Each individual received a questionnaire, a
neurological examination, neurobehavioural testing,
and blood and urine analyses. Most workers also
underwent nerve conduction testing, although this
was not performed at four testing sessions due to the
unavailability of the testers and equipment. One
individual refused to undergo nerve conduction test-
ing but participated in other phases of the evalua-
tion. Testing was performed during normal working
hours in plant premises. In some instances, produc-
tion constraints required that workers return to their
jobs before finishing the entire testing sequence
resulting in incomplete data files for a few individu-
als.
The questionnaire included detailed occupational,
medical, hobby and social histories, including
specific questions on alcohol intake and educational
background. A physician performed the neurologi-
cal examination.
Nerve conduction testing'6 was performed in a
warm room using a Teca 4 electromyograph, equip-
ped with differential amplifiers and an electronic
averager. Each response was recorded using a
fibreoptic graphic recorder, and response amp-
litudes and latencies were measured directly from
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the permanent record. Distances were measured
with a tape measure. The skin temperature of each
extremity was measured during testing using surface
electrodes attached to a digital reading thermostat
and was maintained at 33-36°C during testing by
warming or cooling as needed. Motor responses
were obtained using supramaximal stimulation. Sen-
sory responses were elicited using 32 repetitive
stimuli with responses averaged electronically and
recorded. The recording electrode position was var-
ied to ensure that sensory responses were recorded
directly over the nerve being studied. The right arm
and leg were studied in all individuals.
Neurobehavioural testing procedures described in
greater detail previously'7 included subtests of the
Wechsler Memory Scale (WMS),'8 the Wechsler
Adult Intelligence Scale (WAIS),'9 the Continuous
Performance Test,20 the Santa Ana Dexterity Test,2'
and the Profile of Mood States (POMS).22 Testing
was performed by, or under the direction of, a clini-
cal neuropsychologist using the procedures specified
in the administration manual for each test. To
reduce administration time, alternate items of the
vocabulary subtest of the WAIS were used.
Whole blood lead concentrations were deter-
mined by anodic stripping voltammetry23 on venous
blood samples obtained by venepuncture in lead
free vacuum tubes. Blood lead analyses before
October 1980 were performed by a certified state
laboratory. The commercial laboratory (Environ-
mental Science Associates, Bedford, MA) which
performed our analyses subsequently is also certified
by the Center for Disease Control (CDC) for lead
analysis and has been used as a reference laboratory
by the CDC. This laboratory performs all analyses in
duplicate and accepts only those results that agree
within 5%. Blood zinc protoporphyrin determina-
tions were performed but analytical errors were dis-
covered which forced us to discard the results.
Exhaled breath carbon monoxide levels were meas-
ured before and after behavioural testing using the
Ecolyzer (Energetics Science Co).
To assess the comparability, of blood lead con-
centrations obtained from the two laboratories, 28
blood samples obtained from another population
were split between the two laboratories and a linear
regression equation was derived to relate the results
from the two laboratories. The results ranged from
12 to 96 ,ug/100 ml and agreed well (r = 0.92). The
equation relating the two laboratories was:
Commercial lab value = 6-97 + (0-961 x state lab
value)
This equation was used to adjust the state values to
those of the commercial laboratory.
STATISTICAL ANALYSES
Exposure characterisation - Using blood test
results and employment histories, we calculated the
time weighted average blood lead concentration
over the 12 month period before our testing
(TWA-12 months) as a summary of cumulative past
exposure for foundry workers only. The blood lead
concentration measured on the day of testing was
used to indicate current exposure. Blood lead con-
centrations of exposed workers during the months
before being hired were assumed to equal the mean
level for unexposed workers.
Control ofconfounding - To adjust for the effects
of age, sex, and education on neurobehavioural
tests, and the effects of age, height, weight, and limb
temperature on nerve conduction measurements,
multiple linear regression analysis24 of the data
obtained from the unexposed population was used
to develop a prediction equation for each test. Pre-
dicted values were derived for each individual using
these equations, and the ratio of actual to predicted
was computed (and multiplied by 100) to give a per-
cent predicted value for each individual's perfor-
mance on each test. A more detailed explanation of
this process as it relates to our neurobehavioural
tests appears elsewhere.'"
Evaluation of dose response relationships - To
assess the relationship of current blood lead con-
centration to test performance, individuals were
grouped into four exposure categories, according to
blood lead concentration on the day of testing, anr
the group means of the percent predicted values for
each test were calculated. An exposure group whose
performance was comparable to the referent popu-
lation on a particular test should have an average
percent predicted score near 100. In most tests, if
lead exposure impairs performance, test scores for
those in the higher exposure groups average below
100%. The opposite relationship holds for five of
the POMS subtests (all except the Vigor scale): in
this case large raw scores indicate an adverse effect
and, therefore, percent predicted scores increase
with excess reporting of symptoms. To evaluate the
cumulative effect of lead exposure, the TWA- 12
months exposure measure and appropriate con-
founding variables were included in a multiple
regression analysis. The one sided significance level
(p value) of the exposure term was calculated using
the t statistic.24 One sided testing was thought to be
justified since no previous study has shown lead
exposure to have a beneficial effect on neurological
function.
Results
GROUP CHARACTERISTICS
Blood lead concentrations of the "unexposed"
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Table 1 Characteristics ofpopulation (n = 160)
Age Mean (range) 32-4 (18-62)
Company duration (months) Mean (range) 33-6 (0-252)
Job duration (months) Mean (range) 23-4 (0-252)
Years of schooling Mean (range) 10-9 (5-16)
No of men (%) 129 (80-6)
Alcohol consumption:
Non-drinker 17 (10-6)
Drink less than once a week 40 (25-0)
Drink once a week to less
than once a day 69 (43-1)
Drink once or more a day 33 20-6)
Not known 1 0-6)
Blood lead concentration(.ig/ml) Mean (range) 32-8 (10-80)
workers ranged from 10 to 42 ,g/100 ml, while the
exposed ranged from 13 to 80 Ag/100 ml. In view of
this overlap between the two groups we combined
the groups and stratified them in subsequent analy-
ses based on measured blood lead concentrations.
As a result, the two lowest exposure strata (current
blood lead concentration: 0-20 ,ugI1OO ml and
21-40 ,ug/100 ml) contain individuals from both the
foundry and the assembly plant. Table 1 shows the
characteristics of the composite population.
SYMPTOM RATES
We did not observe increased reporting of abdomi-
nal colic or other gastrointestinal symptoms typically
associated with overt plumbism (table 2). In fact, the
only symptom reported in excess was excessive
tiredness, and this was noted only by individuals
with blood lead concentrations above 60,g/dl. The
relative paucity of workers with blood lead concent-
rations above 60 Ag/dl restricts the usefulness of
data from this group for these and subsequent anal-
yses. Individuals with blood concentrations between
40 and 60 ,gldl did not report symptoms to a grea-
ter extent than those with lower blood concentra-
tions.
Table 2 Symptom prevalence rates by blood lead concentration on the day of testing
Current blood lead concentration (Mg/dl)
Symptom 0-20 (n = 26) 21-40 (n = 97) 41-60 (n = 28) 61-80 (n = 9)
Jointpain 7-7% 11-6% 11-1% 111%
Numb arms 19-2 11-6 10-7 33-3
Numb legs 15-4 4-2 0 0
Weak arms 0 3-2 7-1 0
Weak legs 0 4-2 3-6 0
Incoordination 3-9 2-1 3-6 11 1
Headache 4-4 2-2 0 22-2
-Iffitability 17-4 4-3 7-1 11 1
Increased sleeping 8-7 5-4 10-7 11 1
Excessive tiredness 23-1 105 14-3 66-7
Confusion 0 2-1 0 22-2
Trouble remembering 115 9 5 10-7 33-3
Abdominal cramps 0 2-1 0 11-1
Nausea 3-9 1-1 0 11-1
Vomiting 7-7 0 3-6 0
Table 3 Nerve conduction testing by blood lead concentration on day of testing, mean (SE)
Current blood lead concentration (pgldl)
0-20 (n = 20) 21-40 (n = 75) 41-60 (n = 17) 61-80 (n = 5)
Ulnar nerve
Motor conduction:
Velocity (forearm) (m/s) 62-48 (1-75) 63-54 (0.92) 64-57 (2-58) 63-44 (1-43)
Amplitude (stimulation at wrist) (mv) 10-26 (0.48) 10-07 (0.27) 8-76 (0.56) 8-40 (0.78)
Amplitude (stimulation at elbow) (mv) 9-65 (050) 9-20 (0.26) 7-82 (0.45) 7-30 (0-77)
Distal latency (wrist time) 2-55 (0.10) 2-59 (0-04) 2-69 (0-12) 2-28 (0-12)
Sensory conduction:
Velocity (m/s) 51-76 (1-50) 53-40 (0.74) 53-32 (1-81) 55-13 (1-56)
Amplitude (mv) 15-61 (1-48) 13-28 (0-74) 13-27 (1-37) 13-00 (1-53)Peroneal nerve
Motor conduction:
Velocity (m/s) 50-82 (1-35) 49-92 (0-59) 49-88 (1-90) 52-61 (2-32)
Amplitude (stimulation at ankle) (mv) 5-15 (0.53) 5-20 (0.27) 5-53 (0.33) 7-10 (1-62)
Amplitude (stimulation at fibular head) (mv) 4-48 (0-50) 4-65 (0.25) 470 (0.39) 7-00 (1-41)
Distal latency (time) 4-42 (0-29) 4-27 (0.09) 4-21 (0-16) 3-66 (0-16)Sural nerve
Sensory conduction:
Velocity (m/s) 48-70 (1-20) 47-84 (0-51) 46-29 (0.88) 45-40 (2-91)
Amplitude (mv) 16-42 (1-70) 14 32 (0-84) 14-10 (1-26) 11-40 (2-52)
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Table 4 Regression analysis ofexposure indices versus nerve conduction parameters
Nerve conduction parameter Significance level for exposure coefficient*
Current blood lead level Average exposure for previous 12 months
Ulnar nerve
Motor conduction (n = 65):
Velocity (forearm) 050 0-21
Amplitude (wrist stimulation) 0-03 0-02
Amplitude (elbow stimulation) 0-003 0004
Distal latency (wrist time) 0 47 0 70
Sensory conduction (n = 58):
Velocity 0-10 0-02
Amplitude 0-16 0-06
Peroneal nerve
Motor conduction (n = 60):
Velocity 0-70 0-36
Amplitude (ankle stimulation) 0-35 0-36
Amplitude (fibular head stimulation) 0-64 0.55
Distal latency (time) 0-16 0 09
Sural nerve
Sensory conduction (n = 60):
Velocity 0-02 0 03
Amplitude 0-01 0-01
* Each tabulated value is significance level (p-value) associated with coefficient of an exposure index in a multiple linear regression model.
The p-value corresponds to a one sided t test of the hypothesis that exposure has no effect on nerve conduction-that is, the exposure
coefficient is zero. The regression model also incorporates terms that adjust for age, height, and weight (and limb temperature for the
velocity parameters).
Table 5 Neurobehavioural testing by blood lead concentration on day of testing, mean (SE)
Current blood lead concentration (pug/dl)
0-20 (n = 26) 21-40 (n = 97) 41-60 (n = 28) 61-80 (n = 9)
Wechsler Adult Intelligence Scale:
Vocabulary 36-15 (3.49) 38-99 (1-49) 35-96 (3-33) 30 00 (4-89)
Similarities 13-11 (1-26) 14-40 (0-47) 11-19 (0-95) 12-44 (1-23)
Block design 32-19 (1-60) 33-96 (0 84) 31-16 (1-59) 35 33 2.37)
Digit symbol 49 00 (2-01) 53-54 (1-30) 48-50 (2-46) 50 56 3-21)
Digit symbol: recall 6 54 (0-43) 6-62 (0-25) 5-83 (0 46) 6 33 0-99)
Wechsler Memory Scale:
Information 5-29 (0-17) 5 36 (0-11) 4-55 (0-25) 5 33 (0.24)
Orientation 4 94 (0.06) 4-91 (0.03) 4-73 (0-12) 4-67 (0-17)
Mental control 6-82 (0-38) 7-08 (0-18) 6-68 (0.42) 5-67 (0.96)
Logical memory B 5-65 (0-68) 6-81 (046) 5-64 (0.87) 6-33 1-25))
Digit span: forward 6 59 (0-21) 6-38 0.13) 6-64 (0 19) 6-00 0-37)
Digit span: backward 4 35 (024) 4-56 0-12) 3-88 (030) 4-00 0.29)
Visual reproduction 9-88 (0 70) 10-07 0-30) 8-14 (0 70) 8-67 (1-14)
Paired associate learning 13-32 1-79) 16-02 (0-96) 11-58 (1-47) 11-44 2-91)
Continuous Performance:
Mean response latency (msec) 485-0 (23.4) 447-9 (10-8) 462-4 (16-3) 524-5 (35-1)
Prop e of mood states:
Tension 10-73 (1-46) 10-49 (0.59) 9-60 (0.99 15-11 (1-80)
Anger 7-85 (1.21) 7-81 (078) 9-20 (1-29 12-89 (2.49)
Depression 7-27 1.46) 8-03 0 94) 7-68 (1-46 12-78 (3.51
Vigour 17-46 (1-13) 18-57 00-59 17-60 (1-28 14-00 (155j
Fatigue 7-35 1-38) 6-28 0-49 7-80 (1-11) 10-33 (224'
Confusion 6-81 (0-82) 5-88 0.44) 6-08 (0.62) 10-33 (1-89S
Santa Ana:
Preferred 22-52 (0.83) 24-64 (0.35) 23-14 (0.62) 24-72 (0.88)
Non-preferred 23-31 (0.83) 23-66 (0.38) 22-17 (0.67) 23-11 (1-11)
Both 29-55 (1-49) 31-41 (0-79) 29-80 (1-27) 29-00 (1-18)
NERVE CONDUCTION TESTING
Motor conduction in the ulnar and peroneal nerves
did not deteriorate with increasing blood lead con-
centration except for reductions in the amplitude of
the evoked motor potentials in the ulnar nerve(table 3). Modest slowing of sensory conduction and
reduction of response amplitude were seen in the
sural nerve. Regression analysis (table 4), using
either current or cumulative (TWA 12 months)
exposure indices, confirms these associations. In
most instances current and cumulative exposure
indices correlated equally well with effect paramet-
ers.
Occupational lead neurotoxicity: a behavioural and electrophysiological evaluation
1201 (jg/dl)
1 -00-20
2 = 21-40
3= 41-60100- 4= 61-80
T= SE
90-
, 60°
30
1 2 3 4 1 2 3 4 1 2-3 4 1 2 3 4 1 2 3 4 1 2 3
VOCABUL SIMILAR DIG SYM SAi MON MENTCON VIS f
Verbal coroept Visual/motor Mowryformation performonceY
Fig 1 Mean percent predicted scores on selected neurobehavioural tests by level oflead
exposure.
Blood lead
concentration(lug/dl)
1 = 00-20
2= 21-40
3 = 41-60
4 = 61-80
T= SE
3 4
REP
1 2 3 4 1 2 3 4 1 2 3 4 1 23 4 1 2 3 4 1 2 3 4
TENSION ANGER DEPRESS VIGOR FATIGUE CONFUSE
Mood
Fig 2 Mean percent predicted scores on the profile ofmood states (POMS) by level oflead
exposure.
357
Baker, Feldman, White, Harley, Niles, Dinse, and Berkey
Blood lead
concentration
(Ai /dl)
1 =00-20
2 =21-40
3=41-60
4 = 61-80
T= SE
t 00
50-
1 23 4 1 2 34 123 4 1 23 4
GRINDER CORER MELTER GRINDER
Fatigue Ai
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NEUROBEHAVIOURAL TESTING
Impairment in neurobehavioural function was par-
ticularly apparent in performance on tests of verbal
concept formation, selected memory tests, and
mood profile for individuals with blood lead con-
centrations above 40 ,ug/dl when comparing either
mean raw scores (table 5) or adjusted scores (figs 1
and 2). Those with blood levels over 60 ,Lg/dl
showed even greater degrees of dysfunction. Tests
that were sensitive to the effects of lead included the
vocabulary and similarities subtests of the WAIS;
the digit span (backwards), paired associate learn-
ing, mental control, and visual reproduction subtests
of the WMS; and most of the POMS subtests.
Since some of the behavioural functions could
have been influenced by job stress and aspects of the
work experience which were correlated with lead
exposure level, confounding by job characteristics
was evaluated. Since subjective reports of mood are
1 2 34 12 34
CORER MELTER
nger
particularly sensitive to such job specific influences,
we analysed scores on the POMS test within indi-
vidual job category using the three largest job
groups in the foundry, 12 melter pourers, 41 core
makers, and 19 grinders. These jobs have different
demands and levels of apparent health risk. Increas-
ing reports of anger and fatigue were seen as blood
lead concentrations increased for all job categories
(fig 3).
Multiple regression analysis (table 6) showed that
exposure level was significantly correlated (p <
0-05) with performance on tests of visual intellig-
ence, memory, and various subtests of the POMS. A
borderline association (p = 0.06) was seen between
cumulative exposure and response latency on the
continuous performance test. Current exposure
level correlated with neurobehavioural test perfor-
mance somewhat better than did cumulative expos-
ure.
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Table 6 Regression analysis ofexposure indices versus neurobehavioural tests
Significance level for exposure coefficient*
Current blood lead concentration Average exposure for previous 12 months
Wechsler Adult Intelligence Scale (n = 151):
Vocabulary
Similarities
Block design
Digit symbol
Digit symbol: recall
Paired associate learning
Wechsler Memory Scale (n = 124):
Information
Orientation
Mental control
Logical memory
Digit span: forward
Digit span: backward
Visual reproduction
Other tests:
Continuous performance (n = 130)
(mean response latency)
Profile of mood states (n = 153)
Tension
Anger
Depression
Vigour
Fatigue
Confusion
Santa Ana dexterity (n = 134)
Preferred hand
Non-preferred hand
Both hands
0-04
0-04
0-51
0-74
0-37
0-12
0-32
0-42
0-02
0-78
0-54
0-09
0-23
0-08
0-19
0-41
0-92
0-79
0-77
0-68
0-36
0-16
0-75
0-50
0-24
0-65
0-16
0-07
0-01
0-04
0-55
0-05
0-01
0-21
0-15
0-51
0-06
0-06
0-01
0-02
0-65
0-002
0-04
0-43
0-26
0-58
* Each tabulated value is the significance level (p value) associated with the coefficient of an exposure index in a multiple linear regression
model. The p value corresponds to a one sided t test of the hypothesis that exposure has no effect on test performance - that is, the
exposure coefficient is zero. Regression model also incorporates terms that adjust for age, gender, and education.
Discussion
These data support the view that lead exposure in
adults causes dose dependent impairment of
neurobehavioural function. Lead toxicity in these
workers was manifested primarily as a disturbance
in mood (leading to increased reports of depression,
fatigue, tension, anger, and confusion). Short term
memory (partially visual memory), psychomotor
speed and dexterity, and verbal concept formation
were also affected. Nerve conduction abnormalities
were limited primarily to mild disruption in sensory
conduction of the ulnar and sural nerves. These
signs of toxicity occurred in individuals who did not
report the classic symptoms of lead poisoning (colic,
constipation, or wrist weakness for example) and
whose blood lead concentrations were relatively low
(below 80 Ag/dl) and had never exceeded 90 ,ug/dl.
We have controlled for confounding as an expla-
nation for these results by developing multivariate
prediction equations based on a referent popula-
tion'" which allowed us to control for age, sex, and
education effects on neurobehavioural tests and age,
height, weight, and limb temperature in nerve con-
duction testing. As a result, confounding by these
determinants of test outcome was minimised. We
also investigated potential confounding effects of
alcohol consumption, and carbon monoxide expos-
ure, although these factors may have influenced test
performance in some cases, they were not correlated
with lead exposure level and, as such, would not
distort the results.25 Information bias was not likely
since testers and testees were not aware of the blood
lead concentration of individuals being tested.
Within job groups, where perception of level of lead
exposure would have been comparable among
workers sharing the same job duties (fig 3), dose
related changes in central nervous system symp-
tomatology were seen.
Our data confirm and extend prior reports of
impaired neurobehavioural performance in workers
exposed to lead. We saw limited evidence of lead
related impairment of psychomotor speed and dex-
terity, which has been reported by others in
adults'-IO and children.26 We did observe effects of
lead on short term memory and verbal intelligence.
Our observation of mood changes in lead workers
has not been related to blood lead concentrations in
the manner reported here, although previous
descriptions of lead toxicity27 28 have noted increased
central nervous system symptomatology.
The dose response assessment performed in this
study suggests significant adverse neurobehavioural
effects on adults with blood lead concentrations of
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40-60 ,g/dl. Although prior work by Hanninen et al
indicates psychomotor slowing and impaired visual
intelligence in workers with blood lead concentra-
tions in this range,4 effects on memory, verbal intel-
ligence, and mood have not been clearly shown at
this level of exposure. The reports of Valciukas et
al'2 and Grandjean et al'3 include individuals with
blood lead concentrations above 60 ,Ag/dl and do not
present stratified analyses of data which would per-
mit comparison with the current form of analysis.
Qualitatively, the types of neurobehavioural
abnormality that we noted are similar to those noted
at higher exposure levels in these reports. Increased
rates of subjective symptoms of fatigue, forgetful-
ness, and restlessness were reported by Repko,"
Baker et al,27 and Lilis et al28 in individuals with
blood lead concentrations below 80 ,ug/dl.
We did not observe impaired nerve conduction
velocities in motor nerves as previously noted by
Seppalainen and Hernberg,s Araki and Honma,6
Buchthal and Behse,' and Feldman et al.8 Since
exposure levels were somewhat lower among our
group than in some studies, a failure to find an
association may reflect different dose levels. We did
note modest loss of amplitude in the ulnar and sural
nerves which has been observed by others and may
correlate with subtle histological axonal changes
previously noted in lead exposed workers.7
From these observations, it appears that initial
signs of lead toxicity in adults become manifest in
the central nervous system (CNS) as abnormalities
of memory, psychomotor functions, and abstract
concept formation well before overt disruption of
the peripheral nervous system (PNS) occurs. Pre-
dominance of CNS effects after lead exposure may
be attributable to selective vulnerability of the cen-
tral nervous system resulting in a different dose
response relationship between the central and
peripheral nervous systems. Dysfunction of the PNS
manifesting as slowed nerve conduction appears to
require moderately raised blood lead concentrations
(usually exceeding 60 ,ug/dl) for an extended period
(usually more than six months). Central nervous sys-
tem effects seem to occur at somewhat lower blood
lead concentrations and may occur sooner. Our
findings contrast directly with the previous view that
lead neurotoxicity affects primarily the peripheral
nervous system in adults and the central nervous
system in children. CNS effects do appear early in
the course of adult lead toxicity.
Lucille Pothier programmed the statistical analyses,
Betsy White and Anne Fidler provided invaluable
help in data collection and study organisation, and
Melinda Tuhus and Lisa Gallatin typed the original
manuscript.
Research supported in part by Research Grant No
OH0984-02 from the National Institute for Occu-
pational Safety and Health and a Center Grant No
ES00002-20 from the National Institute of
Environmental Health Sciences.
Requests for reprints to: Dr Baker, Harvard School
of Public Health, 677 Huntington Avenue, Boston,
MA 02115.
References
'Sassa S, Kappas A, Levere RD. Studies in lead poisoning. I. Mic-
roanalysis of erythrocyte protoporphyrin levels by spec-
troflourometry in the detection of chronic lead intoxication in
the subclinical range. Biochem Med 1975;8:135-48.
2 Bull RJ. Lead and energy metabolism. In: Singhal RL, Thomas
JA, eds. Lead toxicity. Baltimore-Munich: Urban and
Schwarzenberg, 1980.
Waldron HA. Lead poisoning in the ancient world. Med Hist
1973; 17:391-9.
4Baker EL. Neurologic and behavioural disorders. In: Levy BS,
Wegman DH, eds. Occupational health: recognition and pre-
vention of work-related disease. Boston: Little, Brown and Co,
1982.
Seppalainen AM, Hemberg S. Subclinical lead neuropathy.
American Journal of Industrial Medicine 1980; 1:413-20.
6 Araki S, Honma T. Relationships between lead absorption and
peripheral nerve conduction velocities in lead workers. ScandJ
Work Environ Health 1976;4:225-31.
7Buchthal F, Behse F. Electrophysiology and nerve biopsy in men
exposed to lead. Br J Ind Med 1979;36:135-47.
Feldman RG, Hayes MK, Younes R, Aldrich FD. Lead
neuropathy in adults and children. Arch Neurol
1977;34:481-8.
Spivey GH, Baloh RW, Brown CP, et al. Subclinical effects of
chronic increased lead absorption: a prospective study.
II. Results of baseline neurologic testing. JOM 1979;21:490-
6.
0 Spivey GH, Baloh RW, Brown CP, et al. Subclinical effects of
chronic increased lead absorption: a prospective study. III.
Neurologic findings at follow-up examination. JOM
1980;22:607-12.
"Repko JD, Corum CR, Jones PD, Garcia LS. The effects of inor-
ganic lead on behavioural and neurologic function. Cincinnati:
US Dept of Health, Education, and Welfare, National Insti-
tute for Occupational Safety and Health, 1978. (DHEW
(NIOSH) pub No 78-128.)
Valciukas JA, Lilis R, Eisinger J, Blumberg WE, Fischbein A,
Selikoff IJ. Behavioural indicators of lead neurotoxicity:
results of a clinical field survey. Int Arch Occup Environ
Health 1978;41:217-36.
Grandjean P, Arnvig E, Beckmann J. Psychological dysfunctions
in lead-exposed workers: relation to biological parameters of
exposure. Scand J Work Environ Health 1978;4:295-303.
'4 Hanninen H, Hernberg S, Mantere P, Vesanto R, Jalkanen M.
Psychological performance of subjects with low, exposure to
lead. JOM 1978;20:683-9.
5 Hernberg S. Evaluation of epidemiologic studies in assessing the
long-term effects of occupational noxious agents. Scand J
Work Environ Health 1980;6: 163-9.
Ih Goodgold J, Eberstein A. Electrodiagnosis ofneuromuscular dis-
eases. 2nd ed. Baltimore: Williams and Wilkins Co, 1977.
7 Baker EL, Feldman RG, White RF, Harley JP, Dinse GE, Ber-
key CS. Monitoring neurotoxins in industry - development of
a neurobehavioural test battery. JOM 1983;25: 125-30.
360
Occupational lead neurotoxicity: a behavioural and electrophysiological evaluation 361
18 Wechsler D. A standardised memory scale for clinical use. J 24 Kleinbaum DG, Kupper LL. Applied regression analysis and
Psychol 1945; 19:87-95. other multivariate methods. North Scituate, MA: Duxbury
Wechsler D. Wechsler adult intelligence scale manual. New York: Press, 1978.
Psychological Corporation, 1955. 25 Miettinen OS, Cook F. Confounding: essence and detection. Am
20 Rosvold H, Mirsky A, Sarason I, Bronsome E, Beck L. A con- J Epidemiol 1981; 114:593-603.
tinuous performance test of brain damage. J Consult Clin 26 Needleman HL, Gunnoe C, Leviton A, et al. Deficits in
Psychol 1956;20:343-50. psychologic and classroom performance of children with ele-
21 Hanninen H, Lindstrom K. Behavioural test battery for Toxico vated dentine lead levels. N Engl J Med 1979;300:689-95.
psychological studies. Helsinki: Institute of Occupational 27 Baker EL, Landrigan PJ, Barbour AG, et al. Occupational lead
Health, 1976. poisoning in the United States: clinical and biochemical
22 McNair DM, Lorr M, Droppleman LF. EITS manual - profile of findings related to blood lead levels. Br J Ind Med
mood states, San Diego: Educational and Industrial Testing 1979;36:314-22.
Service, 1971. 2' Lilis R, Fischbein A, Eisinger J, et al. Prevalence of lead disease
23 Searle B, Chan W, Davidow B. Determination of lead in blood among secondary lead smelter workers and biological indi-
and urine by anodic stripping voltammetry. Clin Chem cators of lead exposure. Environ Res 1977;14:255-85.
1973; 19:76-80.
